Ampio Pharmaceuticals Has Approved A 20-to-1 Reverse Stock Split To Be Effective At 4:01 pm ET On September 11
Portfolio Pulse from Benzinga Newsdesk
Ampio Pharmaceuticals has approved a 20-to-1 reverse stock split, which will be effective at 4:01 pm ET on September 11.
August 31, 2023 | 10:33 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ampio Pharmaceuticals' 20-to-1 reverse stock split may lead to a temporary increase in stock price, but it does not change the company's underlying value.
A reverse stock split reduces the number of shares outstanding, which can lead to a temporary increase in the stock price. However, it does not change the company's market capitalization or its underlying value. Therefore, the impact on the stock price is likely to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100